Edwards Lifesciences Corporation
$81.76-2.85 (-3.37%)
Prev Close
$84.61
Open
$85.13
High
$85.33
Low
$81.34
Volume
3.72M
Market Cap
$49.14B
P/E
44.68
Div Yield
—
Over the past 12 months, insider activity at Edwards Lifesciences Corporation (EW) has been exclusively selling, with 0 insider purchases totaling $0.00 and 54 insider sales totaling $22.46M. The most recent insider transaction was by Lippis Daniel J. (officer: CVP, TAVR), who sold $87.0K worth of shares on Mar 11, 2026. Edwards Lifesciences Corporation operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $49.14B.
Buys (12M)
0
$0.00
Sells (12M)
54
$22.46M
Net Activity
Net Seller
$22.46M
Active Insiders
10
last 12 mo
EW Price Chart
EW Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Lippis Daniel J. | officer: CVP, TAVR | Sell | 1,019 | $85.38 | $87.0K | 33,933.9 |
| Mar 11, 2026↗ | Ullem Scott B. | officer: CVP, Chief Financial Officer | Sell | 13,000 | $84.92 | $1.10M | 47,600 |
| Mar 2, 2026↗ | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 11,340 | $85.93 | $974.4K | 21,266.3 |
| Feb 26, 2026↗ | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 24,000 | $83.84 | $2.01M | 21,266.3 |
| Feb 22, 2026↗ | Dahl Andrew M. | SVP, Corporate Controller | Sell | 176 | $79.78 | $14.0K | 0 |
| Feb 22, 2026↗ | Lippis Daniel J. | CVP, TAVR | Sell | 432 | $79.78 | $34.5K | 0 |
| Feb 16, 2026↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 199 | $75.87 | $15.1K | 0 |
| Feb 13, 2026↗ | Zovighian Bernard J | director, officer: CEO | Sell | 22,430 | $76.67 | $1.72M | 103,794 |
| Feb 12, 2026↗ | Lippis Daniel J. | CVP, TAVR | Sell | 456 | $75.87 | $34.6K | 0 |
| Jan 9, 2026↗ | Lippis Daniel J. | officer: CVP, TAVR | Sell | 2,038 | $85.70 | $174.7K | 22,001.9 |
| Jan 6, 2026↗ | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 22,680 | $85.66 | $1.94M | 40,578.3 |
| Dec 12, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,386 | $83.76 | $953.7K | 0 |
| Dec 12, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 1,019 | $84.03 | $85.6K | 0 |
| Dec 12, 2025↗ | STONE HEISZ LESLIE | Director | Sell | 2,615 | $83.41 | $218.1K | 0 |
| Dec 11, 2025↗ | Chopra Daveen | CVP, TMTT & Surgical | Sell | 2,000 | $84.38 | $168.8K | 0 |
| Dec 10, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,340 | $83.83 | $950.6K | 0 |
| Dec 10, 2025↗ | Zovighian Bernard J | CEO | Sell | 25,350 | $84.95 | $2.15M | 0 |
| Dec 9, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 7,700 | $84.47 | $650.4K | 0 |
| Dec 8, 2025↗ | Markowitz Wayne | CVP, JAPAC | Sell | 583 | $86.01 | $50.1K | 0 |
| Nov 10, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 1,020 | $82.55 | $84.2K | 0 |
| Nov 10, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 13,000 | $83.08 | $1.08M | 0 |
| Sep 15, 2025↗ | Dahl Andrew M. | SVP, Corporate Controller | Sell | 262 | $77.57 | $20.3K | 0 |
| Sep 15, 2025↗ | Markowitz Wayne | CVP, JAPAC | Sell | 650 | $77.57 | $50.4K | 0 |
| Aug 25, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 2,500 | $81.95 | $204.9K | 0 |
| Aug 18, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $78.06 | $698.7K | 0 |
| Jul 28, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 4,114 | $79.46 | $326.9K | 0 |
| Jul 11, 2025↗ | Bruls Annette | CVP, EMEACLA | Sell | 109 | $78.80 | $8.6K | 0 |
| Jul 7, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 333 | $76.79 | $25.6K | 0 |
| Jun 16, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $75.23 | $673.3K | 0 |
| Jun 3, 2025↗ | Zovighian Bernard J | CEO | Sell | 17,066 | $77.22 | $1.32M | 0 |
| Jun 2, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 2,570 | $77.40 | $198.9K | 0 |
| May 22, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 1,500 | $75.07 | $112.6K | 0 |
| May 13, 2025↗ | Zovighian Bernard J | CEO | Sell | 2,860 | $73.68 | $210.7K | 0 |
| May 12, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 816 | $73.68 | $60.1K | 0 |
| May 12, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 580 | $73.68 | $42.7K | 0 |
| May 12, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 271 | $73.68 | $20.0K | 0 |
| May 12, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 1,200 | $73.68 | $88.4K | 0 |
| May 12, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 988 | $73.68 | $72.8K | 0 |
| May 9, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 851 | $74.92 | $63.8K | 0 |
| May 9, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 627 | $74.92 | $47.0K | 0 |
| May 9, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 330 | $74.42 | $24.6K | 0 |
| May 9, 2025↗ | Markowitz Wayne | GM & SVP, Surgical | Sell | 568 | $74.99 | $42.6K | 0 |
| May 9, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 12,656 | $74.46 | $942.4K | 0 |
| May 9, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 819 | $74.92 | $61.4K | 0 |
| May 9, 2025↗ | Zovighian Bernard J | CEO | Sell | 4,253 | $74.92 | $318.6K | 0 |
| May 6, 2025↗ | Zovighian Bernard J | CEO | Sell | 7,050 | $75.02 | $528.9K | 0 |
| May 5, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 988 | $75.65 | $74.7K | 0 |
| May 5, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 580 | $75.65 | $43.9K | 0 |
| May 5, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 472 | $75.65 | $35.7K | 0 |
| May 5, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 1,283 | $75.65 | $97.1K | 0 |
| May 5, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 806 | $75.65 | $61.0K | 0 |
| Apr 14, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 9,500 | $69.81 | $663.2K | 0 |
| Apr 8, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 300 | $70.61 | $21.2K | 0 |
| Mar 26, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 11,250 | $70.87 | $797.3K | 0 |
| Mar 13, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 9,500 | $67.96 | $645.6K | 0 |
| Mar 10, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 400 | $69.48 | $27.8K | 0 |
| Mar 10, 2025↗ | Zovighian Bernard J | CEO | Sell | 6,164 | $69.51 | $428.4K | 0 |
| Feb 28, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 11,250 | $70.78 | $796.3K | 0 |
| Feb 24, 2025↗ | Dahl Andrew M. | SVP, Corporate Controller | Sell | 176 | $73.30 | $12.9K | 0 |
| Feb 18, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 601 | $76.19 | $45.8K | 0 |
| Feb 18, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 174 | $76.19 | $13.3K | 0 |
| Feb 18, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 333 | $76.19 | $25.4K | 0 |
| Feb 14, 2025↗ | LORANGER STEVEN R | Director | Sell | 5,739 | $76.42 | $438.6K | 0 |
| Feb 13, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 6,500 | $75.75 | $492.4K | 0 |
| Feb 13, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 500 | $76.34 | $38.2K | 0 |
| Feb 13, 2025↗ | STONE HEISZ LESLIE | Director | Sell | 5,739 | $75.86 | $435.4K | 0 |
| Feb 13, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 11,250 | $75.76 | $852.3K | 0 |
EW Insider Buying Activity
The following table shows recent insider purchases of Edwards Lifesciences Corporation (EW) stock reported via SEC Form 4 filings.
No insider buying activity found for EW in the last 12 months.
EW Insider Selling Activity
The following table shows recent insider sales of Edwards Lifesciences Corporation (EW) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Lippis Daniel J. | officer: CVP, TAVR | Sell | 1,019 | $85.38 | $87.0K | 33,933.9 |
| Mar 11, 2026↗ | Ullem Scott B. | officer: CVP, Chief Financial Officer | Sell | 13,000 | $84.92 | $1.10M | 47,600 |
| Mar 2, 2026↗ | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 11,340 | $85.93 | $974.4K | 21,266.3 |
| Feb 26, 2026↗ | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 24,000 | $83.84 | $2.01M | 21,266.3 |
| Feb 22, 2026↗ | Dahl Andrew M. | SVP, Corporate Controller | Sell | 176 | $79.78 | $14.0K | 0 |
| Feb 22, 2026↗ | Lippis Daniel J. | CVP, TAVR | Sell | 432 | $79.78 | $34.5K | 0 |
| Feb 16, 2026↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 199 | $75.87 | $15.1K | 0 |
| Feb 13, 2026↗ | Zovighian Bernard J | director, officer: CEO | Sell | 22,430 | $76.67 | $1.72M | 103,794 |
| Feb 12, 2026↗ | Lippis Daniel J. | CVP, TAVR | Sell | 456 | $75.87 | $34.6K | 0 |
| Jan 9, 2026↗ | Lippis Daniel J. | officer: CVP, TAVR | Sell | 2,038 | $85.70 | $174.7K | 22,001.9 |
| Jan 6, 2026↗ | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 22,680 | $85.66 | $1.94M | 40,578.3 |
| Dec 12, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,386 | $83.76 | $953.7K | 0 |
| Dec 12, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 1,019 | $84.03 | $85.6K | 0 |
| Dec 12, 2025↗ | STONE HEISZ LESLIE | Director | Sell | 2,615 | $83.41 | $218.1K | 0 |
| Dec 11, 2025↗ | Chopra Daveen | CVP, TMTT & Surgical | Sell | 2,000 | $84.38 | $168.8K | 0 |
| Dec 10, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,340 | $83.83 | $950.6K | 0 |
| Dec 10, 2025↗ | Zovighian Bernard J | CEO | Sell | 25,350 | $84.95 | $2.15M | 0 |
| Dec 9, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 7,700 | $84.47 | $650.4K | 0 |
| Dec 8, 2025↗ | Markowitz Wayne | CVP, JAPAC | Sell | 583 | $86.01 | $50.1K | 0 |
| Nov 10, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 1,020 | $82.55 | $84.2K | 0 |
| Nov 10, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 13,000 | $83.08 | $1.08M | 0 |
| Sep 15, 2025↗ | Dahl Andrew M. | SVP, Corporate Controller | Sell | 262 | $77.57 | $20.3K | 0 |
| Sep 15, 2025↗ | Markowitz Wayne | CVP, JAPAC | Sell | 650 | $77.57 | $50.4K | 0 |
| Aug 25, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 2,500 | $81.95 | $204.9K | 0 |
| Aug 18, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $78.06 | $698.7K | 0 |
| Jul 28, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 4,114 | $79.46 | $326.9K | 0 |
| Jul 11, 2025↗ | Bruls Annette | CVP, EMEACLA | Sell | 109 | $78.80 | $8.6K | 0 |
| Jul 7, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 333 | $76.79 | $25.6K | 0 |
| Jun 16, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $75.23 | $673.3K | 0 |
| Jun 3, 2025↗ | Zovighian Bernard J | CEO | Sell | 17,066 | $77.22 | $1.32M | 0 |
| Jun 2, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 2,570 | $77.40 | $198.9K | 0 |
| May 22, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 1,500 | $75.07 | $112.6K | 0 |
| May 13, 2025↗ | Zovighian Bernard J | CEO | Sell | 2,860 | $73.68 | $210.7K | 0 |
| May 12, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 816 | $73.68 | $60.1K | 0 |
| May 12, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 580 | $73.68 | $42.7K | 0 |
| May 12, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 271 | $73.68 | $20.0K | 0 |
| May 12, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 1,200 | $73.68 | $88.4K | 0 |
| May 12, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 988 | $73.68 | $72.8K | 0 |
| May 9, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 851 | $74.92 | $63.8K | 0 |
| May 9, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 627 | $74.92 | $47.0K | 0 |
| May 9, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 330 | $74.42 | $24.6K | 0 |
| May 9, 2025↗ | Markowitz Wayne | GM & SVP, Surgical | Sell | 568 | $74.99 | $42.6K | 0 |
| May 9, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 12,656 | $74.46 | $942.4K | 0 |
| May 9, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 819 | $74.92 | $61.4K | 0 |
| May 9, 2025↗ | Zovighian Bernard J | CEO | Sell | 4,253 | $74.92 | $318.6K | 0 |
| May 6, 2025↗ | Zovighian Bernard J | CEO | Sell | 7,050 | $75.02 | $528.9K | 0 |
| May 5, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 988 | $75.65 | $74.7K | 0 |
| May 5, 2025↗ | Chopra Daveen | CVP, TMTT | Sell | 580 | $75.65 | $43.9K | 0 |
| May 5, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 472 | $75.65 | $35.7K | 0 |
| May 5, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 1,283 | $75.65 | $97.1K | 0 |
| May 5, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 806 | $75.65 | $61.0K | 0 |
| Apr 14, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 9,500 | $69.81 | $663.2K | 0 |
| Apr 8, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 300 | $70.61 | $21.2K | 0 |
| Mar 26, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 11,250 | $70.87 | $797.3K | 0 |
| Mar 13, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 9,500 | $67.96 | $645.6K | 0 |
| Mar 10, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 400 | $69.48 | $27.8K | 0 |
| Mar 10, 2025↗ | Zovighian Bernard J | CEO | Sell | 6,164 | $69.51 | $428.4K | 0 |
| Feb 28, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 11,250 | $70.78 | $796.3K | 0 |
| Feb 24, 2025↗ | Dahl Andrew M. | SVP, Corporate Controller | Sell | 176 | $73.30 | $12.9K | 0 |
| Feb 18, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 601 | $76.19 | $45.8K | 0 |
| Feb 18, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 174 | $76.19 | $13.3K | 0 |
| Feb 18, 2025↗ | Wood Larry L | Global President TAVR & Surg | Sell | 333 | $76.19 | $25.4K | 0 |
| Feb 14, 2025↗ | LORANGER STEVEN R | Director | Sell | 5,739 | $76.42 | $438.6K | 0 |
| Feb 13, 2025↗ | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 6,500 | $75.75 | $492.4K | 0 |
| Feb 13, 2025↗ | Lippis Daniel J. | CVP, JAPAC | Sell | 500 | $76.34 | $38.2K | 0 |
| Feb 13, 2025↗ | STONE HEISZ LESLIE | Director | Sell | 5,739 | $75.86 | $435.4K | 0 |
| Feb 13, 2025↗ | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 11,250 | $75.76 | $852.3K | 0 |
EW Insiders
Similar Stocks to EW
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.31+0.77%
$19.73B
PODD
Insulet Corporation
$221.28-6.34%
$17.40B